Team:Freiburg bioware/Notebook/April

From 2009.igem.org

(Difference between revisions)
Line 39: Line 39:
  class="t">The Team</span></a>
  class="t">The Team</span></a>
     <ul>
     <ul>
-
       <li><a href="#">Overview</a></li>
+
       <li><a href="https://2009.igem.org/Team:Freiburg_bioware/Team">Overview</a></li>
-
       <li><a href="#">Photos</a></li>
+
       <li><a href="https://2009.igem.org/Team:Freiburg_bioware/Team/Portraits">Portraits</a></li>
     </ul>
     </ul>
   </li>
   </li>
Line 63: Line 63:
     </ul>
     </ul>
   </li>
   </li>
-
   <li><a href="#"><span class="l"></span><span
+
   <li><a href="https://2009.igem.org/Team:Freiburg_bioware/Notebook"><span class="l"></span><span
  class="r"></span><span class="t">Notebook</span></a></li>
  class="r"></span><span class="t">Notebook</span></a></li>
   <li><a
   <li><a

Revision as of 10:37, 19 October 2009

FREiGEM

  April

24th April 12:30 - 18:00 o'clock Manuel

Literaturrecherche zu FokI.
Entstandene Ideen:
  • three oligo's: two for binding the monomers and one to create a dsDNA where FokI can bind.
  • two oligo's: one for binding one monomer, the second for binding the second monomer and to create dsDNA (one monomer has to be inactivated).
  • one oligo: both binding sites of the monomers on one oligo (also one monomer has to be inactivated).

The 196 C-terminale aminoacids of FokI were used from other groups (see reference 1). Primersequences are also provided in the publication.
Reference 1: Freiburg09_FokI_Zn-Finger_1996.pdf

29th april 21o'clock Rüdiger


contact:  freigem09@googlemail.com

Retrieved from "http://2009.igem.org/Team:Freiburg_bioware/Notebook/April"